Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents

By Neckers Len   Neckers Katharine  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 277-288

Informa Healthcare

Access to resources Recommend Favorite

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

By Patel Hardik J   Modi Shanu   Chiosis Gabriela   Taldone Tony  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 559-587

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors in antineoplastic therapy: is it all wrapped up?

By Isaacs Jennifer S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 569-589

Informa Healthcare

Access to resources Recommend Favorite

Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010

By Messaoudi Samir   Peyrat Jean-François   Brion Jean-Daniel   Alami Mouad  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1501-1542

Informa Healthcare

Access to resources Recommend Favorite

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

By Jhaveri Komal   Ochiana Stefan O   Dunphy Mark PS   Gerecitano John F   Corben Adriana D   Peter Radu I   Janjigian Yelena Y   Gomes-DaGama Erica M   Koren John   Modi Shanu   Chiosis Gabriela  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 611-628

Informa Healthcare

Access to resources Recommend Favorite